Cargando…

Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients

Detalles Bibliográficos
Autores principales: Field, Malgorzata, Splevins, Andrew, Picaut, Philippe, van der Schans, Marcel, Langenberg, Jan, Noort, Daan, Snyder, Daniel, Foster, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410060/
https://www.ncbi.nlm.nih.gov/pubmed/30781899
http://dx.doi.org/10.3390/toxins11020115
_version_ 1783402145409662976
author Field, Malgorzata
Splevins, Andrew
Picaut, Philippe
van der Schans, Marcel
Langenberg, Jan
Noort, Daan
Snyder, Daniel
Foster, Keith
author_facet Field, Malgorzata
Splevins, Andrew
Picaut, Philippe
van der Schans, Marcel
Langenberg, Jan
Noort, Daan
Snyder, Daniel
Foster, Keith
author_sort Field, Malgorzata
collection PubMed
description
format Online
Article
Text
id pubmed-6410060
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64100602019-04-01 Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients Field, Malgorzata Splevins, Andrew Picaut, Philippe van der Schans, Marcel Langenberg, Jan Noort, Daan Snyder, Daniel Foster, Keith Toxins (Basel) Correction MDPI 2019-02-13 /pmc/articles/PMC6410060/ /pubmed/30781899 http://dx.doi.org/10.3390/toxins11020115 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Field, Malgorzata
Splevins, Andrew
Picaut, Philippe
van der Schans, Marcel
Langenberg, Jan
Noort, Daan
Snyder, Daniel
Foster, Keith
Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
title Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
title_full Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
title_fullStr Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
title_full_unstemmed Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
title_short Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
title_sort correction: field, m. et al. abobotulinumtoxina (dysport(®)), onabotulinumtoxina (botox(®)), and incobotulinumtoxina (xeomin(®)) neurotoxin content and potential implications for duration of response in patients
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410060/
https://www.ncbi.nlm.nih.gov/pubmed/30781899
http://dx.doi.org/10.3390/toxins11020115
work_keys_str_mv AT fieldmalgorzata correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients
AT splevinsandrew correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients
AT picautphilippe correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients
AT vanderschansmarcel correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients
AT langenbergjan correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients
AT noortdaan correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients
AT snyderdaniel correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients
AT fosterkeith correctionfieldmetalabobotulinumtoxinadysportonabotulinumtoxinabotoxandincobotulinumtoxinaxeominneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients